The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable...

China`s 14th Five-Year Plan (FYP) covering the period from 2021 to 2025 will only be published after its acceptance by the National People`s Congress in March 2021.

Invista Performance Technologies (IPT) has won two separate contracts to supply its PTA technology for projects in China and Turkey.

Catalent Gene Therapy, a unit of US-based CDMO Catalent, is spending $130 million on five new Phase 3-through commercial-scale manufacturing suites at its gene therapy...

AstraZeneca has temporarily paused Phase 2/3 global clinical trials of the adenovirus-viral vector-based Covid-19 candidate it is developing for Oxford University. The...

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

DSM has formed a 50:50 joint venture with Dutch industrial manufacturing group VDL Groep to produce medical facemasks and components in the Netherlands.

Air Liquide has entered into a long-term agreement with Eastman Chemical for the supply of additional gaseous oxygen, nitrogen and syngas. The extra volumes will support...

To help meet surging demand for Covid-19 diagnostics, US diagnostic specialist Thermo Fisher Scientific has completed a new $40 million production plant for viral...